Moderna will charge governments between $ 25 and $ 37 per dose of its Covid-19 candidate vaccine, depending on the quantity requested, Chief Executive Stephane Bancel told the German weekly Welt am Sonntag (WamS). “So our vaccine costs about the same as a flu shot, which is between $ 10 …
Read More »
Prime Minister Narendra Modi held a meeting on Friday to review India’s vaccination strategy in which issues such as prioritization of population groups and the technological platform for the deployment of the vaccine for the coronavirus were discussed. Modi tweeted that the meeting discussed important topics related to the progress …
Read More »
The global search for an effective coronavirus vaccine is still underway, as more than 57 million people have contracted the disease so far and more than 1.3 million have lost their lives from it. The pharmaceutical companies Pfizer and Moderna recently declared that their vaccine candidates have been successful in …
Read More »
A year has passed since the first novel cases Coronavirus Infections were detected in the Chinese province of Wuhan. In this period, the global scientific community together with government regulators have opened new paths to develop and test vaccines against COVID-19 that can end the pandemic. These efforts have begun …
Read More »
The American biotechnology company Moderna announced on November 16 that its Covid vaccine is 94.5% effective. The US-German collaboration of Pfizer and BioNTech had previously made a similar announcement. These two “mRNA” vaccines are the most promising candidates undergoing phase 3 human trials now, and the vaccines could begin in …
Read More »
NEW DELHI: As the national expert group on the Covid-19 vaccine strengthens plans for the procurement and distribution of injections, the Center is betting on the five candidate vaccines currently in clinical trials in India. Candidates include three that are in advanced stages of trials in India: the Oxford-AstraZeneca candidate …
Read More »
NEW DELHI: India hopes that five locally tested vaccines will help control Covid-19, as those developed by Pfizer and Moderna may not be available in large quantities soon. The five candidates include Russia’s Sputnik-V, whose “Phase II going to Phase III” tests in India will begin next week in collaboration …
Read More »
National equity indices hit new all-time highs on Tuesday as positive news from Moderna Inc, that its Covid-19 vaccine has a 94.5 percent success rate, boosted investor sentiment. The indices broke their previous highs hit on November 14 during the one-hour Muhurat Trading special. Among top-tier indices, the S&P BSE …
Read More »
The Dow hit a record Monday after Moderna became the second American company in a week to report positive results from its COVID-19 vaccine test, raising hopes for a faster economic recovery from a recession led by a pandemic. Moderna Inc soared 7.7% as it said its experimental vaccine was …
Read More »
Moderna Inc (MRNA.O) said Monday that its experimental vaccine was 94.5% effective in preventing Covid-19 according to interim data from a late-stage clinical trial, becoming the second American company in a week to report results that far exceed. The expectations. Along with the vaccine from Pfizer Inc. (PFE.N), which has …
Read More »